In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy

Archives of Neurology

Volumn 59, Issue 12, 2002, Pages 1882-1886

  Knowlton, Robert C ^a   Abou Khalil, Bassel ^b   Sawrie, Stephen M ^a   Martin, Roy C ^a   Edward Faught, R ^a   Kuzniecky, Ruben I ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AMINO ACID SYNTHESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DRUG UPTAKE; ENERGY METABOLISM; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMAGE ANALYSIS; IN VIVO STUDY; INTERMETHOD COMPARISON; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; TREATMENT INDICATION;

ADOLESCENT; ADULT; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUORODEOXYGLUCOSE F18; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036894999     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.12.1882     Document Type: Article

References (40)

1. Achten E, Santens P, Boon P, et al. Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy. AJNR Am J Neuroradiol. 1998;19:1-8.
2. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: A series of 100 patients. Ann Neurol. 1997;42:737-746.
3. Knowlton RC, Laxer KD, Ende G, et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol. 1997;42:829-837.
4. 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology. 1998;51:66-71.
5. 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med. 1997;37:18-23.
6. Henry TR, Babb TL, Engel J Jr, et al. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol. 1994;36:925-927.
7. 1H spectroscopic imaging in mesial temporal lobe epilepsy: Correlation with histopathology of mesial temporal sclerosis [abstract]. Neurology. 2000;54(suppl 3):A4.
8. Hajek M, Wieser HG, Khan N, et al. Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy. Neurology. 1994;44: 2125-2132.
9. 1H magnetic resonance spectroscopic imaging. Ann Neurol. 1996;40:236-239.
10. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: Evidence from proton MR spectroscopic imaging. Neurology. 1997;49:1525-1533.
11. 1H magnetic resonance spectroscopy study. Magn Reson Med. 1995;33:595-600.
12. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci. 1999;354:1155-1163.
13. Engel JJ, Kuhl DE, Phelps ME. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science. 1982;218:64-66.
14. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science. 1988;241:462-464.
15. Cendes F, Stanley JA, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurol. 1997;41:74-81.
16. Rubin E, Dhawan V, Moeller JR, et al. Cerebral metabolic topography in unilateral temporal lobe epilepsy. Neurology. 1995;45:2212-2223.
17. 1H-SI shows bilateral metabolite changes in unilateral TLE patients with and without hippocampal atrophy. In: Proceedings of the Third Annual Meeting of the Society of Magnetic Resonance; August 19-25, 1995; Nice, France.
18. Engel JJ. Outcome with respect to epileptic seizures. In: Engel JJ, ed. Surgical Treatment of the Epilepsies. New York, NY: Raven Press; 1987:553-571.
19. Talairach J, Tournoux P. Coplanar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme-Stratton Inc; 1988.
20. Vaughan JT, Hetherington HP, Otu JO, Pan JW, Pohost GM. High frequency volume coils for clinical NMR imaging and spectroscopy. Magn Reson Med. 1994;32:206-218.
21. Pan JW, Vaughan JT, Kuzniecky RI, Pohost GM, Hetherington HP. High resolution neuroimaging at 4.1T. Magn Reson Imaging. 1995;13:915-921.
22. Hetherington H, Kuzniecky R, Pan J, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol. 1995;38:396-404.
23. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 1994;44:1411-1417.
24. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging. Radiology. 1994;193:465-472.
25. Cross JH, Connelly A, Jackson GD, et al. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol. 1996;39:107-113.
26. Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes: A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain. 1966;89:499-530.
27. Bruehl C, Witte OW. Cellular activity underlying altered brain metabolism during focal epileptic activity. Ann Neurol. 1995;38:414-420.
28. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 1995;46:531-540.
29. Labbe C, Froment JC, Kennedy A, Ashburner J, Cinotti L. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord. 1996;10:141-170.
30. Strauss WL, Tsuruda JS, Richards TL. Partial volume effects in volume-localized phased-array proton spectroscopy of the temporal lobe. J Magn Reson Imaging. 1995;5:433-436.
31. 18FDG-PET. Magn Reson Med. 2000;43:244-250.
32. Hetherington HP, Pan JW, Chu WJ, Mason GF, Newcomer BR. Biological and clinical MRS at ultra-high field. NMR Biomed. 1997;10:360-371.
33. Berlinguet L, Laliberte M. Biosynthesis of N-acetyl-L-aspartic acid in vivo and in brain homogenates. Can J Biochem. 1970;48:207-211.
34. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Husted CA, Weinger MW. Lateralization of human focal epilepsy by 31P magnetic resonance spectroscopic imaging. Neurology. 1992;42:2011-2018.
35. Aasly J, Silfvenius H, Aas TC, et al. Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res. 1999;35:211-217.
36. Hill RA, Chiappa KH, Huang-Hellinger F, Jenkins BG. Hemodynamic and metabolic aspects of photosensitive epilepsy revealed by functional magnetic resonance imaging and magnetic resonance spectroscopy. Epilepsia. 1999;40:912-920.
37. 1H MRS studies in vivo. Neuroreport. 1996;7:1397-1400.
38. Dautry C, Vaufrey F, Brouillet E, et al. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab. 2000;20: 789-799.
39. Berkovic SF, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibres (MERRF), I: A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain. 1989;112: 1231-1260.
40. Kunz WS, Kudin AP, Vielhaber S, et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol. 2000;48:766-773.